Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice

Tomita, Kengo, Teratani, Toshiaki, Suzuki, Takahiro, Shimizu, Motonori, Sato, Hirokazu, Narimatsu, Kazuyuki, Okada, Yoshikiyo, Kurihara, Chie +15 more·2014·Hepatology

DOI 10.1002/hep.26604

Cited by (316)

Items 101–200 of 316

Design of Hepatic Targeted Drug Delivery Systems for Natural Products: Insights into Nomenclature Revision of Nonalcoholic Fatty Liver Disease
Rou Tang, Rui Li, He Li, Xiaolei Ma, Peng Du, Xiao-You Yu, Ling Ren, Lulu Wang, Wensheng Zheng · 2021 · ACS Nano
Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism
Hui Miao, Hao Ouyang, Qian Guo, Mengjuan Wei, Bin Lü, Guoyin Kai, Lili Ji · 2022 · The Journal of Nutritional Biochemistry
Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
Michiko Itoh, Atsushi Tamura, S KANAI, Miyako Tanaka, Yohei Kanamori, Ibuki Shirakawa, Ayaka Ito, Yasuyoshi Oka, Isao Hidaka, Taro Takami et al. · 2023 · The Journal of Experimental Medicine
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
Mazen Noureddin, Quentin Mark Anstee, Rohit Seth Loomba · 2016 · Alimentary Pharmacology & Therapeutics
Non-alcoholic fatty liver disease: What has changed in the treatment since the beginning?
Bülent Baran · 2014 · World Journal of Gastroenterology
Chitinase 3‐like 1 deficiency ameliorates liver fibrosis by promoting hepatic macrophage apoptosis
Masaaki Higashiyama, Kengo Tomita, Nao Sugihara, Hiroyuki Nakashima, Hirotaka Furuhashi, Makoto Nishikawa, Kenichi Inaba, Akinori Wada, Kazuki Horiuchi, Yoshinori Hanawa et al. · 2019 · Hepatology Research
The significance of YKL-40 protein in liver fibrosis
Hui Tao, Jingjing Yang, Kai‐Hu Shi, Cheng Huang, Lei Zhang, Xiongwen Lv, Jun Li · 2014 · Inflammation Research
Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis
Ming-xia Liu, Man Gao, Chun-zhu Li, Cunzhi Yu, Hong Yan, Chun Peng, Yu Li, Chenggang Li, Ze-long Ma, Yang Zhao et al. · 2017 · Acta Pharmacologica Sinica
Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models
Sridhar Radhakrishnan, Steven F Yeung, Jia‐Yu Ke, Maísa Mota Antunes, Michael Pellizzon · 2021 · Current Developments in Nutrition
Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis
Mohamed A. Abdelmegeed, Youngshim Choi, Grzegorz Godlewski, Seung-Kwon Ha, Atrayee Banerjee, Sehwan Jang, Byoung‐Joon Song · 2017 · Scientific Reports
Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet
Yi Ding, Xin Sun, Yuning Chen, Yue Deng, Ke Qian · 2015 · European Journal of Pharmacology
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Pietro Torre, Benedetta Maria Motta, Roberta Sciorio, Mario Masarone, Marcello Persico · 2021 · Frontiers in Medicine
Transient Hepatic Overexpression of Insulin-Like Growth Factor 2 Induces Free Cholesterol and Lipid Droplet Formation
Sonja M. Kessler, Stephan Laggai, Elien Van Wonterghem, Katja Gemperlein, Rolf Müller, Johannes Haybaeck, Roosmarijn E. Vandenbroucke, Manfred Ogris, Claude Libert, Alexandra K. Kiemer · 2016 · Frontiers in Physiology
Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease
Stanislav Nikolaevich Kotlyarov, Aleksei Bulgakov · 2021 · Cells
Role of mitochondrial depolarization and disrupted mitochondrial homeostasis in non-alcoholic steatohepatitis and fibrosis in mice.
Yasodha Krishnasamy, Monika Beck Gooz, Li Li, John J. Lemasters, Zhi Zhong · 2019 · Europe PMC (PubMed Central)
Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Fibrosis
Chun-Ya Lee, Fat‐Moon Suk, Yuh‐Ching Twu, Yi‐Jen Liao · 2020 · International Journal of Environmental Research and Public Health
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease
Guillermo Nahúm López-Sánchez, Mayra Domínguez‐Pérez, Misael Uribe, Norberto Carlos Chávez-Tapia, Natalia Nuño‐Lámbarri · 2020 · Annals of Hepatology
Liver Cholesterol Overload Aggravates Obstructive Cholestasis by Inducing Oxidative Stress and Premature Death in Mice
Natalia Nuño‐Lámbarri, Mayra Domínguez‐Pérez, Baulies‐Domenech Anna, María Jesús Monte, José J.G. Marı́n, Patricia Rosales-Cruz, Verónica Souza, Roxana U. Miranda, Leticia Bucio, Eduardo Esteban Montalvo-Jave et al. · 2016 · Oxidative Medicine and Cellular Longevity
Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis
Yvette Simon, Sonja M. Kessler, Katja Gemperlein, Rainer Maria Bohle, Rolf Müller, Johannes Haybaeck, Alexandra K. Kiemer · 2014 · World Journal of Gastroenterology
Inhibiting miR-21 attenuates experimental hepatic fibrosis by suppressing both the ERK1 pathway in HSC and hepatocyte EMT
Kaiming Wu, Changhong Ye, Lin Lin, Yimin Chu, Meng Ji, Weiping Dai, Xin Ying Zeng, Yong Lin · 2016 · Clinical Science
LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis
Xiangguang Shi, Yahui Chen, Qingmei Liu, Xueqian Mei, Jing Liu, Yulong Tang, Ruoyu Luo, Dayan Sun, Yanyun Ma, Wenyu Wu et al. · 2022 · Clinical and Translational Medicine
Cholesterol is a significant risk factor for non-alcoholic steatohepatitis
Sofie M. A. Walenbergh, Ronit Shiri‐Sverdlov · 2015 · Expert Review of Gastroenterology & Hepatology
Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis
Morikawa, Rei, Nakamoto, Nobuhiro, Amiya, Takeru, Chu, Po-sung, Koda, Yuzo, Teratani, Toshiaki, Suzuki, Takahiro, Kurebayashi, Yutaka, Ueno, Akihisa, Taniki, Nobuhito et al. · 2021 · Journal of Hepatology
Lipidomic profiling of rat hepatic stellate cells during activation reveals a two-stage process accompanied by increased levels of lysosomal lipids
Martijn R. Molenaar, Maya W. Haaker, Arie B. Vaandrager, Martin Houweling, J. Bernd Helms · 2023 · Journal of Biological Chemistry
Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models
Sridhar Radhakrishnan, Jia‐Yu Ke, Michael Pellizzon · 2020 · Current Developments in Nutrition
Cholesterol Induces Nrf-2- and HIF-1<i>α</i>-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis
Kaminsky-Kolesnikov, Yula, Rauchbach, Einat, Abu-Halaka, Diana, Hahn, Michal, García-Ruiz, Carmen, Fernandez-Checa, Jose C., Madar, Zecharia, Tirosh, Oren · 2020 · Oxidative Medicine and Cellular Longevity
PNPLA3 I148M variant impairs liver X receptor signaling and cholesterol homeostasis in human hepatic stellate cells
Bruschi, Francesca Virginia, Claudel, Thierry, Tardelli, Matteo, Starlinger, Patrick, Marra, Fabio, Trauner, Michael · 2019 · Hepatology Communications
Free cholesterol accumulation in liver sinusoidal endothelial cells exacerbates acetaminophen hepatotoxicity via TLR9 signaling
Toshiaki Teratani, Kengo Tomita, Takahiro Suzuki, Hirotaka Furuhashi, Rie Irie, Shigeaki Hida, Yoshikiyo Okada, Chie Kurihara, Hirotoshi Ebinuma, Nobuhiro Nakamoto et al. · 2017 · Journal of Hepatology
Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice
Yuanqiang Zhang, Jing Wen, Dongqing Liu, Zhen Qiu, Qianqian Zhu, R Li, Yubin Zhang · 2021 · Life Sciences
Sterol carrier protein 2 in lipid metabolism and non-alcoholic fatty liver disease: Pathophysiology, molecular biology, and potential clinical implications
Can Xu, Heng Li, Chao‐Ke Tang · 2022 · Metabolism
Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis
Sami Gharbia, Cornel Baltă, Hildegard Herman, Marcel Roșu, Judit Váradi, Ildikó Bácskay, Miklós Vecsernyés, Szilvia Gyöngyösi, Ferenc Fenyvesi, Sorina Nicoleta Voicu et al. · 2018 · Frontiers in Pharmacology
TM7SF3 controls TEAD1 splicing to prevent MASH-induced liver fibrosis
Roi Isaac, Gautam Kumar Bandyopadhyay, Theresa V. Rohm, Sion Kang, Jinyue Wang, Narayan Prasad Pokhrel, Sadatsugu Sakane, Rizaldy C. Zapata, Avraham M. Libster, Yaron Vinik et al. · 2024 · Cell Metabolism
Vitamin A‐coupled liposome system targeting free cholesterol accumulation in hepatic stellate cells offers a beneficial therapeutic strategy for liver fibrosis
Hirotaka Furuhashi, Kengo Tomita, Toshiaki Teratani, Motonori Shimizu, Makoto Nishikawa, Masaaki Higashiyama, Takeshi Takajo, Kazuhiko Shirakabe, Koji Maruta, Yoshikiyo Okada et al. · 2017 · Hepatology Research
Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease
Yuchang Li, Liting Chen, Lu Li, Chantal M. Sottas, Stephanie K. Petrillo, Anthoula Lazaris, Peter P. Metrakos, Hangyu Wu, Yuji Ishida, Takeshi Saito et al. · 2021 · iScience
Longitudinal characterization of diet-induced genetic murine models of nonalcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Lars Verschuren, Robert Kleemann, Kozo Oka · 2019 · Biology Open
Oxysterols and Gastrointestinal Cancers Around the Clock
Urša Kovač, Cene Skubic, Laura Bohinc, Damjana Rozman, Tadeja Režen · 2019 · Frontiers in Endocrinology
Autophagy: A Cellular Guardian against Hepatic Lipotoxicity
Rohit A. Sinha · 2023 · Genes
Targeting Liver X Receptors for the Treatment of Non-Alcoholic Fatty Liver Disease
Hye-Jin Kim, Chaewon Park, Tae Hyun Kim · 2023 · Cells
Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice
Jin-Sik Bae, Jong Min Park, Junghoon Lee, Byung‐Chul Oh, Sang‐Ho Jang, Yun Bin Lee, Young-Min Han, Chan-Young Ock, Ji-Young Cha, Ki‐Baik Hahm · 2016 · Metabolism
Harnessing X‐Ray Energy‐Dependent Attenuation of Bismuth‐Based Nanoprobes for Accurate Diagnosis of Liver Fibrosis
Shiman Wu, Xianfu Meng, Xingwu Jiang, Yelin Wu, Shaojie Zhai, Xiaoshuang Wang, Yanyan Liu, Jiawen Zhang, Xinxin Zhao, Yan Zhou et al. · 2021 · Advanced Science
Loss of SREBP-1c ameliorates iron-induced liver fibrosis by decreasing lipocalin-2
Eun‐Ho Lee, Jae‐Ho Lee, Do Young ‍Kim, Young-Seung Lee, Yunju Jo, Tam Dao, Kyung Eun Kim, Dae‐Kyu Song, Ji Hae Seo, Young‐Kyo Seo et al. · 2024 · Experimental & Molecular Medicine
Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis
Yu Tian, Meng Zhang, Lixia Liu, Zi-chao Wang, Bin Liu, Youcai Huang, Xiaoling Wang, Yunzhi Ling, Furong Wang, Xiaoqiang Feng et al. · 2024 · Frontiers in Immunology
The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL/6N mice
Jeong Hoon Pan, Hanvit Cha, Jingsi Tang, Seoyoon Lee, Suk Hee Lee, Brandy Le, Mersady C. Redding, Sangyub Kim, Mona Batish, Byungwhi Caleb Kong et al. · 2020 · Food & Function
Attenuation of hepatic fibrosis by p-Coumaric acid via modulation of NLRP3 inflammasome activation in C57BL/6 mice
Thi My Tien Truong, Seok Hee Seo, Soonkyu Chung, Inhae Kang · 2022 · The Journal of Nutritional Biochemistry
IGF1 suppresses cholesterol accumulation in the liver of growth hormone-deficient mice via the activation of ABCA1
Kensaku Fukunaga, Hitomi Imachi, Jingya Lyu, Tao Dong, Seisuke Sato, Tomohiro Ibata, Toshihiro Kobayashi, Takuo Yoshimoto, Kazuko Yonezaki, Toru Matsunaga et al. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
The Active Components of Fuzheng Huayu Formula and Their Potential Mechanism of Action in Inhibiting the Hepatic Stellate Cells Viability – A Network Pharmacology and Transcriptomics Approach
Xinrui Xing, Si Chen, Ling Li, Yan Cao, Langdong Chen, Xiaobo Wang, Zhenyu Zhu · 2018 · Frontiers in Pharmacology
Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice
Takafumi Yoshida, Jun Akiba, Takanori Matsui, Kazuo Nakamura, Takao Hisamoto, Mitsuhiko Abe, Yu Ikezono, Fumitaka Wada, Hideki Iwamoto, Tõru Nakamura et al. · 2017 · Digestive Diseases and Sciences
Cellular endo‐lysosomal dysfunction in the pathogenesis of non‐alcoholic fatty liver disease
Jiang Du, Yu Ji, Liang Qiao, Yanli Liu, Juntang Lin · 2019 · Liver International
Wnt antagonist DKK‐1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a‐3p
John Henderson, Stefan Pryzborski, Richard J. Stratton, Steven O’Reilly · 2020 · Experimental Dermatology
Expression and Function of BMP and Activin Membrane-Bound Inhibitor (BAMBI) in Chronic Liver Diseases and Hepatocellular Carcinoma
Florian Weber, Oliver Treeck, Patricia Mester, Christa Buechler · 2023 · International Journal of Molecular Sciences
PNPLA3-I148M Variant Promotes the Progression of Liver Fibrosis by Inducing Mitochondrial Dysfunction
Yusong Gou, Lifei Wang, Jinhan Zhao, Xiaoyi Xu, Hangfei Xu, Fang Xi Xie, Yanjun Wang, Yingmei Feng, Jing Zhang, Yang Zhang · 2023 · International Journal of Molecular Sciences
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts
Zeribe C. Nwosu, Hamed Alborzinia, Stefan Wölfl, Steven Dooley, Yan Liu · 2016 · Frontiers in Physiology
Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation
Yuh‐Ching Twu, Tzong‐Shyuan Lee, Yun‐Lian Lin, Shih‐Ming Hsu, Yuan-Hsi Wang, Chia-Yu Liao, Chung-Kwe Wang, Yu‐Chih Liang, Yi‐Jen Liao · 2016 · International Journal of Molecular Sciences
Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function
Yuan-Hsi Wang, Yuh‐Ching Twu, Chung-Kwe Wang, Fu-Zhen Lin, Chun-Ya Lee, Yi‐Jen Liao · 2018 · International Journal of Molecular Sciences
Metabolic injury of hepatocytes promotes progression of NAFLD and AALD
Carvalho-Gontijo, Raquel, Han, Cuijuan, Zhang, Lei, Zhang, Vivian, Hosseini, Mojgan, Mekeel, Kristin, Schnabl, Bernd, Loomba, Rohit, Karin, Michael, Brenner, David A. et al. · 2022 · Seminars in Liver Disease
Impact of Dietary Fat on the Progression of Liver Fibrosis: Lessons from Animal and Cell Studies
Fangping Jia, Xiao Hu, Takefumi Kimura, Naoki Tanaka · 2021 · International Journal of Molecular Sciences
Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation
Hyeneui Jeong, Jong-Won Kim, Myeon‐Sik Yang, Chul Park, Jong‐Hoon Kim, Chae Woong Lim, Bumseok Kim · 2018 · The American Journal of Chinese Medicine
Cancer-secreted exosomal miR-1246 promotes colorectal cancer liver metastasis by activating hepatic stellate cells
Xiaolong Liu, Jialong Liu, Xuanyin Wang, Yang Zou, Xinyi Tao, Jingyu Li, Meng‐nan Ye, Wanbei Xu, Yunyao Deng, Lixin Liu et al. · 2025 · Molecular Medicine
Hepatic damage caused by long-term high cholesterol intake induces a dysfunctional restorative macrophage population in experimental NASH
Ana Claudia Maretti-Mira, Matthew P. Salomon, Angela M. Hsu, Gary C. Kanel, Lucy Golden‐Mason · 2022 · Frontiers in Immunology
Dual inhibition of ACLY and ACSS2 by EVT0185 reduces steatosis, hepatic stellate cell activation, and fibrosis in mouse models of MASH
Gregory R. Steinberg, Jaya Gautam, James Lally, Russta Fayyazi, E. Grasset, Dipankar Bhattacharya, Gio Fidelito, Elham Ahmadi, Logan K. Townsend, Battsetseg Batchuluun et al. · 2026 · Cell Metabolism
Intracellular hepatitis B virus increases hepatic cholesterol deposition in alcoholic fatty liver via hepatitis B core protein
Yaqi Wang, Ting Wu, Danqing Hu, Xin‐Xin Weng, Xiaojing Wang, Pei‐Jer Chen, Xiaoping Luo, Hongwu Wang, Qin Ning · 2017 · Journal of Lipid Research
Mechanisms of hepatic stellate cell activation as a therapeutic target for the treatment of non-alcoholic steatohepatitis
Takuma Tsuchida · 2019 · Folia Pharmacologica Japonica
Mechanisms and therapeutic insights into MASH-associated fibrosis
Yiwei Zhu, Bishuang Cai · 2025 · Trends in Endocrinology and Metabolism
Non-Alcoholic Fatty Liver Disease and Its Association With Diabetes Mellitus
Jaskamal Padda, Khizer Khalid, Anwar Khedr, Fahriba Tasnim, Ola A Al-Ewaidat, Ayden Charlene Cooper, Gutteridge Jean-Charles · 2021 · Cureus
A Novel Sialoglycopeptide from Gadus morhua Eggs Prevents Liver Fibrosis Induced by CCl 4 via Downregulating FXR/FGF15 and TLR4/TGF-β/Smad Pathways
Hao Yue, Weizhen Cai, Yanqi Li, Xiaoxuan Feng, Ping Dong, Changhu Xue, Jingfeng Wang · 2021 · Journal of Agricultural and Food Chemistry
Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol
Xing-Zi Li, Shi‐You Jiang, Guoqiang Li, Qian-Ru Jiang, Juewan Li, Chenchen Li, Yu-Qin Han, Bao‐Liang Song, Xinran Ma, Wei Qi et al. · 2022 · European Journal of Medicinal Chemistry
Gypenoside L inhibits hepatocellular carcinoma by targeting the SREBP2-HMGCS1 axis and enhancing immune response
Man‐Yu Xiao, Wenjing Pei, Si Li, Fangfang Li, Peng Xie, Hao-Tian Luo, Hye Hyun Yoo, Xiang‐Lan Piao · 2024 · Bioorganic Chemistry
Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players
Robert J. Vincent, Arun Jayant Sanyal · 2014 · Current Pathobiology Reports
A Combination of Mitochondrial Oxidative Stress and Excess Fat/Calorie Intake Accelerates Steatohepatitis by Enhancing Hepatic CC Chemokine Production in Mice
Tadashi Moro, Sachie Nakao, Hideaki Sumiyoshi, Takamasa Ishii, Masaki Miyazawa, Naoaki Ishii, Tadayuki Sato, Yumi Iida, Yoshinori Okada, Masayuki Tanaka et al. · 2016 · PLoS ONE
Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice
Yasodha Krishnasamy, Venkat K. Ramshesh, Monika Beck Gooz, Rick G. Schnellmann, John J. Lemasters, Zhi Zhong · 2016 · PLoS ONE
Metabolic Sparks in the Liver: Metabolic and Epigenetic Reprogramming in Hepatic Stellate Cells Activation and Its Implications for Human Metabolic Diseases
Yeon Jin Roh, Hyeonki Kim, Dong Wook Choi · 2025 · Diabetes & Metabolism Journal
Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: Implications for diabetic dyslipidaemia and steatosis
Ugo Soffientini, Anna-Maria Caridis, Sharron Dolan, Annette Graham · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Free Cholesterol‐Induced Liver Injury in Non‐Alcoholic Fatty Liver Disease: Mechanisms and a Therapeutic Intervention Using Dihydrotanshinone I
Jia‐Wen Shou, Juncai Ma, Xuchu Wang, Xiaoxiao Li, Shu‐Cheng Chen, Byung‐Ho Kang, Pang‐Chui Shaw · 2024 · Advanced Science
Liver sinusoidal endothelial cells in hepatic fibrosis: opportunities for future strategies
Ting Chen, Huan Zhang, Wenqi Shan, Jinxue Zhou, Yanwen You · 2025 · Biochemical and Biophysical Research Communications
Metabolic dysfunction‐associated fatty liver disease directly related to liver fibrosis independent of insulin resistance, hyperlipidemia, and alcohol intake in morbidly obese patients
Susumu Inamine, Masayoshi Kage, Jun Akiba, Takumi Kawaguchi, Sachiyo Yoshio, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Ryuki Hashida, Kouichi Oshiro · 2022 · Hepatology Research
Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease
Bohdan Babiy, Bruno Ramos‐Molina, Luis Ocaña, Silvia Sacristán, Diego Burgos‐Santamaría, Javier Martı́nez-Botas, Rebeca Busto, Rebeca Busto, María Dolores Frutos, Agustı́n Albillos et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Alcohol-induced epigenetic changes prevent fibrosis resolution after alcohol cessation in miceresolution
Michael P. Schonfeld, Maura F. O’Neil, Steven A. Weinman, Irina Tikhanovich · 2023 · Hepatology
Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Farzaneh Iravani, Neda Hosseini, Majid Mojarrad · 2018 · Middle East Journal of Digestive Diseases
iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes
Xingya Zhu, Hongying Gan‐Schreier, Ann-Christin Otto, Yu‐Ting Cheng, Simone Staffer, Sabine Tuma‐Kellner, Alexandra Ganzha, Gerhard Liebisch, Waleé Chamulitrat · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
A novel diet‐induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis
Chieko Ejima, Haruna Kuroda, Sonoko Ishizaki · 2016 · Physiological Reports
Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice?
Hassan Reda Hassan Elsayed, Mohammad El-Nablaway, Basma Othman, Asim Mohammed Abdalla, Eman Mohamad El Nashar, Mostafa Mohammed Abd-Elmonem, Randa El‐Gamal · 2020 · Annals of Anatomy - Anatomischer Anzeiger
Stellate Cells and Hepatic Fibrosis
Daisuke Hasegawa, Michael C. Wallace, Scott L. Friedman · 2015 · Elsevier eBooks
Pathogenesis of Nonalcoholic Fatty Liver Disease
Mariana Verdelho Machado, Anna Mae Diehl · 2018 · Elsevier eBooks
Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model
Naeun Choi, Jong‐Won Kim, Hyeneui Jeong, Dong Gue Shin, Jeong Hun Seo, Jong‐Hoon Kim, Chae Woong Lim, Kang Min Han, Bumseok Kim · 2017 · Journal of Ginseng Research
Optimization enzymatic degradation of chitosan into amphiphilic chitooligosaccharides for application in mitigating liver steatosis and cholesterol regulation
Wessam N. El-Sayed, Jafar A Alkabli, Akram Ahmed Aloqbi, Reda F.M. Elshaarawy · 2021 · European Polymer Journal
Ionizable lipid chemistry in lipid nanoparticles determines delivery efficiency to hepatic stellate cells
Hiroki Muto, Kenji Kubara, Seiji Hitaoka, Yoshihide Osada, Yuta Suzuki · 2025 · Journal of Controlled Release
The Dual-Mode Transition of Myofibroblasts Derived from Hepatic Stellate Cells in Liver Fibrosis
Mengchao Yan, Ye Xie, Jia Yao, Xun� Li · 2023 · International Journal of Molecular Sciences
The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity
Flaminia Ferri, Simone Carotti, Guido Carpino, Monica Mischitelli, Alfredo Cantàfora, Antonio Molinaro, Maria Eva Argenziano, Simona Parisse, Alessandro Corsi, Mara Riminucci et al. · 2021 · International Journal of Molecular Sciences
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Adriana Campos-Espinosa, Carolina Guzmán · 2021 · Journal of Visualized Experiments
Pulmonary Arterial Hypertension and Consecutive Right Heart Failure Lead to Liver Fibrosis
Florian Hamberger, Ekaterina Legchenko, Philippe Chouvarine, Young‐Seon Mederacke, Richard Taubert, Martin Meier, Danny David Jonigk, Georg Hansmann, Ingmar Mederacke · 2022 · Frontiers in Cardiovascular Medicine
Obesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link
Jayavardhan Vulchi, Varun Suryadevara, Pazhanivel Mohan, Sadishkumar Kamalanathan, Jayaprakash Sahoo, Dukhabandhu Naik, Sandhiya Selvarajan · 2023 · Journal of Translational Gastroenterology
Crosstalk in extrahepatic and hepatic system in NAFLD / NASH
Yiliang Duan, Yan Zhu Yang, Shuqiang Zhao, Yuesong Bai, Wenbing Yao, Xiangdong Gao, Jun Yin · 2024 · Liver International
Impact of mitochondrial lipid alterations on liver disease mechanisms and progression
Laura Fàbrega, José Carlos Fernández-Checa, Laura Conde de la Rosa, Carmen García‐Ruiz · 2024 · Exploration of Digestive Diseases
PNPLA3 Genotype, Arachidonic Acid Intake, and Unsaturated Fat Intake Influences Liver Fibrosis in Hispanic Youth with Obesity
Roshonda B. Jones, Lide Arenaza, Claudia Rios, Jasmine F. Plows, Paige K. Berger, Tanya L. Alderete, Jennifer L. Fogel, Krishna S. Nayak, Passant Mohamed, Darryl Hwang et al. · 2021 · Nutrients
Dysbiosis and liver diseases (Review)
Hiroki Nishikawa, Shinya Fukunishi, Akira Asai, Keisuke Yokohama, Hideko Ohama, Shuhei Nishiguchi, Kazuhide Higuchi · 2021 · International Journal of Molecular Medicine
Beneficial Effects of Dietary Tempeh Prepared with Rhizopus stolonifer on Liver Function in Rats Fed with a High-Fat Diet
Tsuyoshi Kameda, Hideyuki Aoki, Yongshou Yang, Dwi Eva Nirmagustina, Akane Iwamoto, Thanutchaporn Kumrungsee, Norihisa Katô, Noriyuki Yanaka · 2018 · Journal of Nutritional Science and Vitaminology
Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH
Mona Hegazy, Shereen Abo Baker Saleh, Ahmed A. Ezzat, Mervat Essam Behiry · 2020 · Diabetes Metabolic Syndrome and Obesity
Angiopoietin‐like protein 4 deficiency augments liver fibrosis in liver diseases such as nonalcoholic steatohepatitis in mice through enhanced free cholesterol accumulation in hepatic stellate cells
Toshiaki Teratani, Kengo Tomita, Akinori Wada, Nao Sugihara, Masaaki Higashiyama, Kenichi Inaba, Kazuki Horiuchi, Yoshinori Hanawa, Shin Nishii, Akinori Mizoguchi et al. · 2020 · Hepatology Research
Protective Effects of Lactobacillus gasseri against High-Cholesterol Diet-Induced Fatty Liver and Regulation of Host Gene Expression Profiles
Tianhua He, Nikita Lykov, Xu Luo, Huiling Wang, Zhanxiang Du, Ziyi Chen, Shitian Chen, Lin Zhu, Ye Zhao, Chi‐Meng Tzeng · 2023 · International Journal of Molecular Sciences
Inhibition of microRNA-33b in humanized mice ameliorates nonalcoholic steatohepatitis
Miyagawa, Sawa, Horie, Takahiro, Nishino, Tomohiro, Koyama, Satoshi, Watanabe, Toshimitsu, Baba, Osamu, Yamasaki, Tomohiro, Sowa, Naoya, Otani, Chiharu, Matsushita, Kazuki et al. · 2023 · Life Science Alliance